James Mitchell
Corporate Officer/Principal bei PAVMED INC.
Profil
James Mitchell has founded Oncodisc, Inc. in 2018, where he currently holds the title of Chief Executive Officer.
He is also currently employed at PAVmed, Inc. as Vice President-Digital Health since 2021.
Aktive Positionen von James Mitchell
| Unternehmen | Position | Beginn |
|---|---|---|
| PAVMED INC. | Corporate Officer/Principal | 01.06.2021 |
Oncodisc, Inc.
 Oncodisc, Inc. Internet Software/ServicesTechnology Services Part of PAVmed, Inc., Oncodisc, Inc. is a private company that is developing the Oncodisc Remote Care Platform (Oncodisc RCP) to personalize care through remote detection of changes in patient health status and enhance doctor-patient communication. The company is based in Walnut Creek, CA. Oncodisc (now Veris Health) is developing data-driven remote care technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology. The company was founded in 2018 by James Mitchell and Andrew Thoreson, and James Mitchell has been the CEO since then. The company was acquired by Veris Health, Inc. from Oncodisc Holdings LLC on June 02, 2021 for $0.16 million. | Chief Executive Officer | 01.01.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PAVMED INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Oncodisc, Inc.
Oncodisc, Inc. Internet Software/ServicesTechnology Services Part of PAVmed, Inc., Oncodisc, Inc. is a private company that is developing the Oncodisc Remote Care Platform (Oncodisc RCP) to personalize care through remote detection of changes in patient health status and enhance doctor-patient communication. The company is based in Walnut Creek, CA. Oncodisc (now Veris Health) is developing data-driven remote care technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology. The company was founded in 2018 by James Mitchell and Andrew Thoreson, and James Mitchell has been the CEO since then. The company was acquired by Veris Health, Inc. from Oncodisc Holdings LLC on June 02, 2021 for $0.16 million. | Technology Services |
